Author: Bill Snyder
NIH grant bolsters research on heart disease, cholesterol
Jan. 21, 2021—Thanks to major funding from the National Institutes of Health (NIH), researchers at Vanderbilt University Medical Center have made major inroads in understanding how high-density lipoprotein (HDL), commonly known as good cholesterol, in some cases may actually contribute to the development of atherosclerosis.
Study finds genetic clues to pneumonia risk and COVID-19 disparities
Jan. 21, 2021—Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.
Bick selected as first VUMC Discovery Scholar in Health and Medicine
Jan. 14, 2021—Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine.
Genome editing technique “rescues” mice from accelerated aging disorder: study
Jan. 6, 2021—Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging.
VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment
Jan. 5, 2021—Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients.
Clinic uses new weapon to treat high-risk COVID patients
Dec. 17, 2020—Vanderbilt University Medical Center has a new weapon in the fight against COVID-19 — an investigational antibody treatment approved last month for emergency use in COVID-19 outpatients at high risk of developing severe disease or requiring hospital care.
Heart failure study seeks to reduce hospitalizations
Dec. 17, 2020—A national study led by researchers at Vanderbilt University Medical Center has found that many patients who arrive at the emergency department (ED) with acute heart failure can be safely discharged with self-care guidance and frequent phone appointments, avoiding the need for hospitalization.
Coronavirus ‘crusaders’ spur VUMC research achievements
Dec. 16, 2020—The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.
A deeper look at out-of-home care
Dec. 15, 2020—Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report.
Exploiting viral vulnerabilities
Dec. 10, 2020—The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections.
Study sheds light on diabetes and COVID interaction
Dec. 10, 2020—COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.
Calkins named Assistant VP for Research at VUMC
Dec. 10, 2020—David Calkins, PhD, director of the Vanderbilt Vision Research Center and vice chair and director for Research of the Department of Ophthalmology and Visual Sciences, has been appointed Assistant Vice President for Research at Vanderbilt University Medical Center.
